Portal de Periódicos da CAPES

New salicylic acid derivatives, double inhibitors of glycolate oxidase and lactate dehydrogenase, as effective agents decreasing oxalate production

2022; Elsevier BV; Volume: 237; Linguagem: Inglês

10.1016/j.ejmech.2022.114396

1768-3254

María Dolores Moya-Garzón, Barbara Rodriguez-Rodriguez, Cristina Martín-Higueras, Francisco Franco-Montalbán, Miguel X. Fernandes, José A. Gómez-Vidal, Ángel L. Pey, Eduardo Salido, Mónica Díaz‐Gavilán,

Microbial metabolism and enzyme function

The synthesis and biological evaluation of double glycolate oxidase/lactate dehydrogenase inhibitors containing a salicylic acid moiety is described. The target compounds are obtained in an easily scalable two-step synthetic procedure. These compounds showed low micromolar IC50 values against the two key enzymes in the metabolism of glyoxylate. Mechanistically they behave as noncompetitive inhibitors against both enzymes and this fact is supported by docking studies. The biological evaluation also includes in vitro and in vivo assays in hyperoxaluric mice. The compounds are active against the three types of primary hyperoxalurias. Also, possible causes of adverse effects, such as cyclooxygenase inhibition or renal toxicity, have been studied and discarded. Altogether, this makes this chemotype with drug-like structure a good candidate for the treatment of primary hyperoxalurias.